A new trading day began on Monday, with Avidity Biosciences Inc (NASDAQ: RNA) stock price up 8.50% from the previous day of trading, before settling in for the closing price of $42.33. RNA’s price has ranged from $4.82 to $48.80 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 148.90% over the last five years. Meanwhile, its annual earnings per share averaged 1.43%. With a float of $108.62 million, this company’s outstanding shares have now reached $117.12 million.
The firm has a total of 253 workers. Let’s measure their productivity.
Avidity Biosciences Inc (RNA) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Avidity Biosciences Inc is 7.26%, while institutional ownership is 93.21%. The most recent insider transaction that took place on Sep 23 ’24, was worth 578,737. In this transaction Chief Human Resources Officer of this company sold 13,153 shares at a rate of $44.00, taking the stock ownership to the 69,018 shares. Before that another transaction happened on Sep 23 ’24, when Company’s CSTO sold 25,000 for $43.95, making the entire transaction worth $1,098,733. This insider now owns 72,718 shares in total.
Avidity Biosciences Inc (RNA) Earnings and Forecasts
#####
According to the Wall Street analysts, stocks earnings will be around 1.43% per share during the next fiscal year.
Avidity Biosciences Inc (NASDAQ: RNA) Trading Performance Indicators
Here are Avidity Biosciences Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 15.78. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 507.48.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.95, a number that is poised to hit -0.72 in the next quarter and is forecasted to reach -3.11 in one year’s time.
Technical Analysis of Avidity Biosciences Inc (RNA)
Analysing the last 5-days average volume posted by the [Avidity Biosciences Inc, RNA], we can find that recorded value of 1.76 million was better than the volume posted last year of 1.38 million. As of the previous 9 days, the stock’s Stochastic %D was 41.60%. Additionally, its Average True Range was 2.38.
During the past 100 days, Avidity Biosciences Inc’s (RNA) raw stochastic average was set at 87.93%, which indicates a significant increase from 85.95% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 60.49% in the past 14 days, which was lower than the 72.90% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $43.66, while its 200-day Moving Average is $28.24. Now, the first resistance to watch is $47.52. This is followed by the second major resistance level at $49.11. The third major resistance level sits at $51.87. If the price goes on to break the first support level at $43.17, it is likely to go to the next support level at $40.41. Should the price break the second support level, the third support level stands at $38.82.
Avidity Biosciences Inc (NASDAQ: RNA) Key Stats
With a market capitalization of 5.38 billion, the company has a total of 95,637K Shares Outstanding. Currently, annual sales are 9,560 K while annual income is -212,220 K. The company’s previous quarter sales were 2,050 K while its latest quarter income was -70,790 K.
